local_hospital

FARMA -MED. Kujawskie Centrum Medyczne Spółka z o.o.;

Address
lock Available on a paid plan

Respiratory Tract Diseases and Immune System Diseases

At FARMA -MED. Kujawskie Centrum Medyczne Spółka z o.o. in Inowroclaw, clinical research in respiratory and allergic disease focuses on improving symptom control and treatment outcomes for adults and children.

  • Chronic Rhinosinusitis studies are evaluating new ways to relieve persistent sinus symptoms and improve daily comfort.
  • Chronic Obstructive Pulmonary Disease research is assessing whether combination inhaled therapy can better protect patients from serious cardiopulmonary complications.
  • Allergic rhinoconjunctivitis and birch pollen-induced allergic rhinitis trials are testing allergy-focused treatments to reduce nasal and eye symptoms.

These studies aim to refine treatment effectiveness and support better long-term management of common airway and allergy conditions.

Musculoskeletal Diseases

Research in musculoskeletal disorders at this site includes work on knee osteoarthritis, with a focus on easing pain and improving mobility for people living with moderate to severe joint symptoms.

  • Knee osteoarthritis studies are comparing treatment options to find approaches that may better reduce pain and functional limitation.
  • The research is designed to help determine whether different chondroitin sulfate products offer similar support for joint health and symptom relief.

This area of investigation is centered on improving everyday function and quality of life for patients with chronic joint disease.

Male Urogenital Diseases

Clinical trials in male urogenital health include studies of erectile dysfunction, with attention to whether men can safely and confidently use a treatment option on their own.

  • Erectile dysfunction research is evaluating patient understanding and safe use of a commonly used therapy.
  • The goal is to support better self-management and informed treatment decisions in everyday practice.

This work highlights practical questions around treatment use, safety, and patient independence.

Bacterial Infections and Mycoses and related allergy research

Although the site’s studies are mainly centered on allergic and respiratory conditions, they also reflect broader interest in disease control across overlapping clinical areas, including immune-related inflammation and symptom relief.

  • Allergic rhinitis and rhinoconjunctivitis studies are examining treatments intended to reduce sneezing, nasal irritation, and eye symptoms.
  • These trials are aimed at improving the effectiveness and usability of therapies for patients with seasonal allergy complaints.
  • The research also supports better understanding of how symptom-focused care can improve daily functioning.

This portfolio shows a practical focus on conditions that affect breathing, comfort, and quality of life across different age groups.

Site Overview

assignment
6
connected trials
corporate_fare
9
sponsors
science
10
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
2
Trials started 6–12 months ago
6
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
9
Active sponsors
4

Sponsor Network

Top 4 by active trials.

lock +3 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
6
Outperforms 70% of sites
public
Therapeutic diversity
5areas
Outperforms 84% of sites
groups
Sponsor diversity
9sponsors
Outperforms 80% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in FARMA -MED. Kujawskie Centrum Medyczne Spółka z o.o.;

lock Showing 1 of 6 trials — the rest is available on a paid plan.

IMP list

lock Showing 1 of 10 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised1Unknown2024-02-262024-02-26

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.